Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
1,493,203
-
Share change
-
-702,251
-
Total reported value
-
$204,733,027
-
Price per share
-
$136.98
-
Number of holders
-
89
-
Value change
-
-$99,284,833
-
Number of buys
-
23
-
Number of sells
-
69
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2016
As of 31 Mar 2016,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,493,203 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, ARS Wealth Advisors, LLC, GOLDMAN SACHS GROUP INC, LPL Financial LLC, BROWN ADVISORY INC, SPC Financial, Inc., SPINNAKER TRUST, ROYAL BANK OF CANADA, and EFG Asset Management (Americas) Corp..
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.